According to Esperion Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 111,869,478. At the end of 2023 the company had 111,869,478 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.11 B | 52.23% |
2022 | 73.48 M | 99.45% |
2021 | 36.84 M | 37.06% |
2020 | 26.88 M | -1.78% |
2019 | 27.37 M | 2.06% |
2018 | 26.81 M | 2.27% |
2017 | 26.22 M | 16.26% |
2016 | 22.55 M | 0.17% |
2015 | 22.51 M | 16.8% |
2014 | 19.27 M | 25.7% |
2013 | 15.33 M | 2022.53% |
2012 | 0.72 M | |
2003 | 4.63 M | 10.61% |
2002 | 4.18 M | 3.87% |
2001 | 4.03 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 5,647,000,000 | 4,947.85% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | 106,300,000 | -4.98% | ๐บ๐ธ USA |
Ultragenyx RARE | 71,664,493 | -35.94% | ๐บ๐ธ USA |
Lexicon Pharmaceuticals
LXRX | 244,925,000 | 118.94% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | 295,759,435 | 164.38% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,219,000 | 68.25% | ๐บ๐ธ USA |